Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03072238
What this trial is testing

Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Hoffmann-La Roche 1,101
Testing effectiveness (Phase 2)Ended earlyNCT00918385
What this trial is testing

Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 57
Large-scale testing (Phase 3)Looking for participantsNCT07751133
What this trial is testing

Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer

Who this might be right for
Prostate CancermHSPCmCRPC
University College, London 1,500
Testing effectiveness (Phase 2)Ended earlyNCT04085991
What this trial is testing

Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstatic Neoplasms+3 more
Sir Mortimer B. Davis - Jewish General Hospital 11
Testing effectiveness (Phase 2)Study completedNCT00111618
What this trial is testing

Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Antisoma Research 70
Testing effectiveness (Phase 2)Study completedNCT03828838
What this trial is testing

Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer

Who this might be right for
Prostate Neoplasm
Radboud University Medical Center 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526
What this trial is testing

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more
OncoC4, Inc. 733
Testing effectiveness (Phase 2)Looking for participantsNCT07230106
What this trial is testing

SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 218
Early research (Phase 1)Looking for participantsNCT05413421
What this trial is testing

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
ORIC Pharmaceuticals 275
Early research (Phase 1)Study completedNCT00002721
What this trial is testing

Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of New Mexico 18
Testing effectiveness (Phase 2)Study completedNCT00003626
What this trial is testing

Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Not applicableEnrolling By InvitationNCT07112209
What this trial is testing

Clinical Study of Rezvilutamide Combined With Docetaxel Chemotherapy in the Treatment of Abiraterone-Resistant Prostate Cancer

Who this might be right for
Pathological and Imaging Examinations Confirmed Metastatic Prostate Cancer
Zhujiang Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00058084
What this trial is testing

Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 80
Early research (Phase 1)Study completedNCT02991911
What this trial is testing

A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
MedImmune LLC 33
Not applicableStudy completedNCT00578409
What this trial is testing

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 758
Large-scale testing (Phase 3)Active Not RecruitingNCT01957436
What this trial is testing

A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
UNICANCER 1,173
Early research (Phase 1)Ended earlyNCT00010127
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 3
Testing effectiveness (Phase 2)Ended earlyNCT00887640
What this trial is testing

Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 11
Large-scale testing (Phase 3)Ended earlyNCT00216060
What this trial is testing

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

Who this might be right for
Metastatic Prostate Cancer
Christopher Sweeney, MBBS 63
Large-scale testing (Phase 3)Study completedNCT00417079
What this trial is testing

XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
NeoplasmsProstatic Neoplasms
Sanofi 755
Next Page